The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021.
Contents
The Week In Cannabis: PharmaCann Could IPO, Tilray & MedMen, First Black CEO At Major Public Co. And More
Below is a recap of the main news related to the cannabis industry and markets for the week of August 20, 2021.
Contents
RIV Capital Ends Q1 2022 With $212.5M On Hand After Announcing $150M Strategic Investment From Scotts Miracle-Gro’s Cannabis-Focused Subsidiary
Cannabis-focused venture capital firm RIV Capital Inc. (TSX: RIV) (OTC: CNPOF), formerly known as Canopy Rivers Inc., reported Monday that it has ended the first quarter of fiscal 2022 with CA$212.5 million ($169.7 million) of cash on hand.
The Week In Cannabis: An Earnings Avalanche, Biden’s Clemency Plans, Cuomo’s Resignation And More
Below is a recap of the main news related to the cannabis industry and markets for the week of August 13, 2021, which was marked by earnings reports out of many of the largest companies in the space – all details below.
ScottsMiracle-Gro Creates New Entity With $150M Strategic Investment To Enable Cannabis Industry Financing
ScottsMiracle-Gro Company's (NYSE: SMG) newly created cannabis-focused subsidiary, The Hawthorne Collective, is lending $150 million to RIV Capital (TSX: RIV) (OTC: CNPOF).
Global Cannabis Stocks Decline 8.7% in Q2, Agrify, KushCo Among Strongest Cannabis Names In June
The Global Cannabis Stock Index fell for the fourth straight month, dropping 4.1% to 57.10.
During the second quarter, the index was down 8.7%.
After gaining 5.2% in 2020 when it ended at 44.39, the index is up 28.6% in 2021 and has gained 94.2% over the past year.
The index dropped 38.3% from its 2021 closing high of 92.48 on February 10.
CIBC Maintains Outperformer on RIV Capital, Lowers Price Target to C$2.5
CIBC analyst John Zamparo maintains RIV Capital (TSX:RIV) with a Outperformer and lowers the price target from C$2.75 to C$2.5.
Cannabis-Focused RIV Capital Reports Q4 And Fiscal Year 2021 Results, Closes Deal With Canopy Growth
Cannabis-focused investment and acquisition company, RIV Capital Inc.
(TSX: RIV) (OTCQX: CNPOF) posted its latest financial earnings report on Thursday, touting a pop in total comprehensive income that hit CA$64.8 million ($53.7 million) in the fourth quarter of 2021.